Cover storyFDA’s Proposed DTC Rule Could End TV Drug Ads
FDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.
Cover storyFDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.

Mankind Pharma secures exclusive India commercialisation rights for Betta's FDA-approved ALK inhibitor Ensartinib, targeting ALK-positive NSCLC patients.
Lantheus presents Phase 3 data for TAUKLARIFY tau-PET agent, meeting all sensitivity and specificity endpoints across 617 scans in early Alzheimer's disease.

UCB's Klygefa becomes the first dual-binding nanobody C5 inhibitor approved in the US for generalized myasthenia gravis, delivered via subcutaneous autoinjector.

Novartis's Cosentyx receives CHMP positive opinion for adolescent HS, triggering label expansion obligations across batch release, packaging, and pharmacovigilance in Europe.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Nov 23
Nov 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

